3-193334980-G-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_198505.4(ATP13A5):​c.1063C>T​(p.Gln355*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0293 in 1,613,820 control chromosomes in the GnomAD database, including 863 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.023 ( 42 hom., cov: 32)
Exomes 𝑓: 0.030 ( 821 hom. )

Consequence

ATP13A5
NM_198505.4 stop_gained

Scores

5
1
1

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 9.68

Publications

16 publications found
Variant links:
Genes affected
ATP13A5 (HGNC:31789): (ATPase 13A5) This gene encodes a member of the P5 subfamily of P-type transport ATPases. P-type ATPases form a large superfamily of cation and lipid pumps that transport inorganic cations and other substrates across cell membranes. P5 ATPases are localized to membranes of the endoplasmic reticulum (ER) and serve many important functions including transport of cargo proteins to the Golgi, glycosylation and cell wall biosynthesis, control of protein insertion orientation, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) degradation, and sensitivity to unfolded protein response (UPR) activators. The encoded protein is organized into three cytoplasmic domains (A, P, and N) and two membrane-embedded domains (T and S). The N-domain binds ATP and serves as a built-in protein kinase, which phosphorylates the P-domain. The A-domain is an intrinsic protein phosphatase, which dephosphorylates the P-domain once during each catalytic cycle. [provided by RefSeq, Jul 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 3-193334980-G-A is Benign according to our data. Variant chr3-193334980-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 402400.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0231 (3512/152282) while in subpopulation NFE AF = 0.0337 (2291/68016). AF 95% confidence interval is 0.0325. There are 42 homozygotes in GnomAd4. There are 1750 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 42 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP13A5NM_198505.4 linkc.1063C>T p.Gln355* stop_gained Exon 10 of 30 ENST00000342358.9 NP_940907.2 Q4VNC0
ATP13A5XM_011512770.3 linkc.1063C>T p.Gln355* stop_gained Exon 10 of 27 XP_011511072.1
ATP13A5XM_047448075.1 linkc.19-3669C>T intron_variant Intron 1 of 19 XP_047304031.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP13A5ENST00000342358.9 linkc.1063C>T p.Gln355* stop_gained Exon 10 of 30 1 NM_198505.4 ENSP00000341942.4 Q4VNC0

Frequencies

GnomAD3 genomes
AF:
0.0231
AC:
3512
AN:
152164
Hom.:
42
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00557
Gnomad AMI
AF:
0.0527
Gnomad AMR
AF:
0.0206
Gnomad ASJ
AF:
0.0110
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.0498
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0337
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.0220
AC:
5520
AN:
251162
AF XY:
0.0219
show subpopulations
Gnomad AFR exome
AF:
0.00499
Gnomad AMR exome
AF:
0.00926
Gnomad ASJ exome
AF:
0.00784
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0491
Gnomad NFE exome
AF:
0.0322
Gnomad OTH exome
AF:
0.0206
GnomAD4 exome
AF:
0.0299
AC:
43716
AN:
1461538
Hom.:
821
Cov.:
31
AF XY:
0.0291
AC XY:
21166
AN XY:
727052
show subpopulations
African (AFR)
AF:
0.00514
AC:
172
AN:
33462
American (AMR)
AF:
0.00859
AC:
384
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00834
AC:
218
AN:
26124
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39692
South Asian (SAS)
AF:
0.00665
AC:
573
AN:
86210
European-Finnish (FIN)
AF:
0.0480
AC:
2564
AN:
53418
Middle Eastern (MID)
AF:
0.00416
AC:
24
AN:
5764
European-Non Finnish (NFE)
AF:
0.0343
AC:
38164
AN:
1111772
Other (OTH)
AF:
0.0267
AC:
1614
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
2156
4313
6469
8626
10782
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1396
2792
4188
5584
6980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0231
AC:
3512
AN:
152282
Hom.:
42
Cov.:
32
AF XY:
0.0235
AC XY:
1750
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00556
AC:
231
AN:
41570
American (AMR)
AF:
0.0205
AC:
314
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0110
AC:
38
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.00560
AC:
27
AN:
4824
European-Finnish (FIN)
AF:
0.0498
AC:
529
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0337
AC:
2291
AN:
68016
Other (OTH)
AF:
0.0156
AC:
33
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
180
360
541
721
901
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0282
Hom.:
231
Bravo
AF:
0.0201
TwinsUK
AF:
0.0418
AC:
155
ALSPAC
AF:
0.0361
AC:
139
ESP6500AA
AF:
0.00545
AC:
24
ESP6500EA
AF:
0.0298
AC:
256
ExAC
AF:
0.0217
AC:
2633
Asia WGS
AF:
0.00520
AC:
18
AN:
3478
EpiCase
AF:
0.0307
EpiControl
AF:
0.0282

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.66
CADD
Pathogenic
44
DANN
Uncertain
1.0
Eigen
Pathogenic
1.2
Eigen_PC
Pathogenic
1.1
FATHMM_MKL
Pathogenic
0.99
D
PhyloP100
9.7
Vest4
0.35
GERP RS
5.9
Mutation Taster
=43/157
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74437357; hg19: chr3-193052769; API